Hikal signs multi-year global CDMO contract with leading agrochemical company 

Hikal has signed a multi-year contract  with a Europe-based global agrochemical company to supply a specialised agrochemical product to  markets worldwide. The contract, signed by Hikal’s Crop Protection division, covers contract  development and manufacturing (CDMO) of the product for which Hikal undertook process  development and scale-up. Commercial launch is expected towards the end of FY 2026–27, with  volumes anticipated to grow progressively as regulatory approvals are secured across global markets. 

The partnership underscores Hikal’s capabilities in process development and commercialisation,  demonstrating its ability to translate customer requirements into long-term manufacturing  opportunities. It also strengthens Hikal’s Crop Protection business by expanding its portfolio of  specialised offerings for global customers. 

Commenting on the development, Sameer Hiremath, Chairman & Managing Director, Hikal said, “This contract marks an important milestone for our Crop Protection business,  converting nearly three years of collaborative development and scale-up into a long-term commercial  partnership. It demonstrates Hikal’s ability to combine deep technical expertise with reliable  manufacturing capabilities to take complex products from development to commercial supply. We are  well positioned to support the planned launch and progressive expansion of supplies across global  markets. 

Hikal partners with global companies across pharmaceuticals, crop protection, animal health and  specialty chemicals, leveraging its research and development, process chemistry and manufacturing  capabilities to support customers from development through commercial production. 

The post Hikal signs multi-year global CDMO contract with leading agrochemical company  appeared first on Express Pharma.